HYAC
Company News
Haymaker Acquisition Corp. III Announces Stockholder Approval of Business Combination with Biote
NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with Biote, and the related p...
Biote Reports Record Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Outlook
IRVING, Texas, March 22, 2022 (GLOBE NEWSWIRE) -- Biote, a high growth, differentiated medical practice-building business within the hormone optimization space, today announced record financial results for the fourth quarter and full year of 2021.
Related Companies
Hexcel Corporation
HXL
Hyster-Yale, Inc.
HY
Haymaker Acquisition Corp. 4 Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HYAC.WS
Haymaker Acquisition Corp. 4 Units, each consisting one Class A Ordinary Share and one-half of one redeemable Warrant
HYAC.U